Chelation Therapy for Patients with Elevated Body Lead Burden and Progressive Renal Insufficiency

Abstract

Chelation therapy seems to slow the progression of renal insufficiency in patients with mildly elevated body lead burden. This implies that long-term exposure to low levels of environmental lead may be associated with impaired renal function in patients with chronic renal disease.